SCHEMBL5510969

SCHEMBL5510969

CC(C)C(C)(C)C(=O)N1CCC(C(=O)O)CC1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
HSD17B10 Q99714 1/20 0.44
HRH3 Q9Y5N1 2/20 0.44
GAA P10253 1/20 0.39
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5516664 0.84 GAA (0.47) HRH3GAAALDH1A1POLB
SCHEMBL5514914 0.81 HRH3 (0.40) LMNAHRH3ALDH1A1HPGDCYP2D6
SCHEMBL5516041 0.81 SMN1; SMN2 (0.43) LMNAHSD17B10HRH3GAAALDH1A1
SCHEMBL7307925 0.81 LMNA (0.59) LMNAHSD17B10GAAMAPTL3MBTL1
SCHEMBL16708787 0.80 HRH3 (0.39) HRH3ALDH1A1POLBCYP2D6KCNH2
SCHEMBL5513382 0.80 HPGD (0.61) LMNAHRH3ALDH1A1HPGD
SCHEMBL5517785 0.80 ALDH1A1 (0.42) LMNAHSD17B10GAAMAPTALDH1A1
SCHEMBL5520234 0.80 KMT2A (0.42) LMNAHSD17B10HRH3GAAHPGD
SCHEMBL12308632 0.78 LMNA (0.49) LMNAHSD17B10HRH3GAAMAPT
SCHEMBL5606073 0.78 LMNA (0.56) LMNAHSD17B10GAAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed